The WHO’s first guideline on GLP-1 therapy marks a major shift in treating obesity as a chronic disease rather than a behavioural issue. It conditionally recommends drugs like semaglutide and tirzepatide for adults with obesity, but only alongside diet, exercise, and counselling. While the therapy shows significant weight loss and metabolic benefits, WHO warns of high costs, limited access, safety gaps, and the need for strong health systems to ensure equitable, long-term care.
Click to View MoreWHO has opened a Pandemic Preparedness and Emergency Response site at AIIMS New Delhi to act as a regional hub. It will strengthen health security through training, simulations, capacity building, and better surveillance. The initiative supports faster responses to outbreaks and aligns India with WHO’s global preparedness strategy.
Click to View MoreScientists have discovered a special type of brain immune cell called microglia that can protect against Alzheimer’s disease by reducing inflammation and slowing the buildup of harmful proteins like amyloid plaques and tau. These cells work through molecules PU.1 and CD28, offering a potential new direction for treatment. Alzheimer’s, a progressive brain disorder causing memory and cognitive decline, is a growing public health challenge globally and in India. Governments are responding with awareness campaigns, healthcare policies, and research initiatives, but challenges like high costs, limited access, and early diagnosis remain. The discovery highlights the promise of combining scientific research, healthcare, and policy to combat Alzheimer’s disease.
Click to View More
© 2025 iasgyan. All right reserved